Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Cancer Cell|March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.Cancer Cell|January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M Gay, C Allison Stewart, Elizabeth M Park, et al.Nature Genetics|August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Claire A Margolis, Natalie I Vokes, et al.Cancer Immunology Research|April 24, 2020
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid TumorsSarah Abou Alaiwi, Amin H Nassar, Wanling Xie, et al.Nature Communications|February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancerLingzhi Hong, Muhammad Aminu, Shenduo Li, et al.Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.Cell Reports. Medicine|March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of conceptMorteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.Nature Communications|April 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insightsSheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.Nature Communications|July 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLCMaliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, et al.Pageof 5